×
About 1,321 results

ALLMedicine™ Radiation Necrosis Center

Research & Reviews  659 results

Reliability of MR Spectroscopy and PET CT in Differentiating Metastatic Brain Tumor Rec...
https://doi.org/10.1016/j.wneu.2021.05.064
World Neurosurgery; Travers S, Joshi K et. al.

May 30th, 2021 - Clinical and/or neuro-imaging changes after whole brain radiation therapy (WBRT) or stereotactic radiosurgery (SRS) for metastatic brain tumor(s) present the clinical dilemma of differentiating tumor recurrence from radiation necrosis. A number of...

Iatrogenic cerebral radiation necrosis.
https://doi.org/10.1136/practneurol-2020-002904
Practical Neurology; Hilton CMH, Specht L et. al.

May 29th, 2021 - Cerebral radiation necrosis is the most serious late reaction to high doses of ionising radiation to the brain, and its treatment is generally unsatisfactory. We present a patient who developed cerebral radiation necrosis after protracted fluorosc...

Radiomics and radiogenomics in gliomas: a contemporary update.
https://doi.org/10.1038/s41416-021-01387-w 10.1093/neuonc/noy131 10.1007/s00401-016-1545-1 10.1148/rg.2017170037 10.3889/oamjms.2015.034 10.1148/radiol.13120118 10.1007/s00330-018-5758-7 10.1007/s11060-017-2587-5 10.1148/radiol.2018171051 10.1016/j.neurad.2014.02.006 10.1007/s11547-016-0720-8 10.1007/s00234-016-1642-9 10.1148/radiol.12122447 10.1007/s00234-015-1500-1 10.1148/radiol.2015151169 10.1016/j.mri.2012.06.010 10.3174/ajnr.A5391 10.1038/ncomms5006 10.1016/j.mric.2016.06.006 10.1016/j.lungcan.2017.10.015 10.1088/1361-6560/ab2f44 10.18383/j.tom.2018.00052 10.1002/jmri.27244 10.3174/ajnr.A4931 10.1371/journal.pone.0125143 10.1117/1.JMI.6.2.024005 10.1109/TMI.2016.2538465 10.1038/srep13087 10.1186/s12859-016-1423-9 10.1109/TPAMI.2005.159 10.1016/j.radonc.2018.03.033 10.3174/ajnr.A5858 10.1016/0031-3203(91)90143-S 10.1109/TSMC.1973.4309314 10.1109/TPAMI.2002.1017623 10.1016/j.eswa.2012.03.029 10.1038/srep37241 10.1038/s41598-018-37615-2 10.1177/0271678X16655549 10.1038/nm.3289 10.1371/journal.pone.0220939 10.1148/radiol.2016161422 10.1038/s41598-017-09048-w 10.1002/jmri.24996 10.1148/radiol.2017160150 10.1093/neuonc/nos335 10.1073/pnas.0801279105 10.1016/j.ejrad.2016.01.013 10.1002/jmri.26010 10.1002/jmri.25835 10.1007/s00330-018-5368-4 10.3174/ajnr.A6075 10.1016/j.ejrad.2019.01.025 10.1016/j.clineuro.2017.12.007 10.1007/s11060-018-2908-3 10.1126/scitranslmed.3002693 10.1038/nm.2682 10.1186/s12967-016-1035-1 10.1126/science.1236062 10.1093/neuonc/nos112 10.1007/s00062-017-0584-x 10.1002/jmri.24913 10.1016/j.diii.2014.06.013 10.1002/jmri.26171 10.1002/nbm.1059 10.1148/radiol.2521081534 10.1002/jmri.26306 10.1002/jmri.22432 10.1016/j.nicl.2018.08.024 10.1016/j.jnci.2016.07.001 10.3390/cells6040045 10.1038/nrclinonc.2012.64 10.1038/s41598-017-18310-0 10.1148/radiol.2016160845 10.1148/radiol.14131691 10.18383/j.tom.2016.00250 10.1016/j.nicl.2018.10.014 10.1093/neuonc/now256 10.1007/s11060-017-2576-8 10.3174/ajnr.A5620 10.1002/mrm.22147 10.4103/ajns.AJNS_81_17 10.1158/1055-9965.EPI-14-0275 10.1093/neuonc/nox092 10.3389/fneur.2019.00460 10.1111/j.1750-3639.2005.tb00115.x 10.1186/1755-8794-7-30 10.3389/fonc.2019.00374 10.1007/s004010000327 10.3171/jns.2006.104.2.233 10.1148/rg.2017160130 10.1155/2018/1729071 10.1002/acm2.12482 10.1118/1.3622605 10.1118/1.3081408 10.1371/journal.pone.0178843 10.1007/s00234-020-02403-1 10.1038/s41598-017-10649-8 10.3389/fnins.2020.00027 10.1148/radiol.2020191145 10.1007/s10278-014-9716-x 10.1186/s13244-019-0795-6 10.1093/neuonc/now135 10.1038/s41568-018-0016-5 10.1007/s00330-017-5108-1 10.1093/neuonc/nox083.197 10.1259/bjr.20160242 10.1109/JBHI.2018.2825027 10.1177/0284185118756951 10.1118/1.4934373 10.1038/s41598-017-14753-7 10.3389/fnins.2019.00810 10.1016/j.suronc.2018.09.002 10.3174/ajnr.A6365 10.18632/oncotarget.17585 10.1007/s11548-017-1691-5 10.1007/s00432-018-2787-1 10.1007/s11060-019-03096-0 10.1016/j.wneu.2019.01.157 10.1186/s12911-020-01163-5
British Journal of Cancer; Singh G, Manjila S et. al.

May 7th, 2021 - The natural history and treatment landscape of primary brain tumours are complicated by the varied tumour behaviour of primary or secondary gliomas (high-grade transformation of low-grade lesions), as well as the dilemmas with identification of ra...

Clinical Review of Computed Tomography and MR Perfusion Imaging in Neuro-Oncology.
https://doi.org/10.1016/j.rcl.2021.01.002
Radiologic Clinics of North America; Trinh A, Wintermark M et. al.

Apr 30th, 2021 - Neuroimaging plays an essential role in the initial diagnosis and continued surveillance of intracranial neoplasms. The advent of perfusion techniques with computed tomography and MR imaging have proven useful in neuro-oncology, offering enhanced ...

Early-onset symptomatic radiation necrosis after stereotactic radiosurgery in the setti...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041142
Medical Dosimetry : Official Journal of the American Asso... Weltman E, Kotecha R

Apr 29th, 2021 - In this brief report, we describe the case of a previously healthy 51-year gentleman who was treated with stereotactic radiosurgery to a dose of 12 Gy to a small right-sided vestibular schwannoma. MRI of the brain performed after treatment reveale...

see more →

Clinicaltrials.gov  661 results

Reliability of MR Spectroscopy and PET CT in Differentiating Metastatic Brain Tumor Rec...
https://doi.org/10.1016/j.wneu.2021.05.064
World Neurosurgery; Travers S, Joshi K et. al.

May 30th, 2021 - Clinical and/or neuro-imaging changes after whole brain radiation therapy (WBRT) or stereotactic radiosurgery (SRS) for metastatic brain tumor(s) present the clinical dilemma of differentiating tumor recurrence from radiation necrosis. A number of...

Iatrogenic cerebral radiation necrosis.
https://doi.org/10.1136/practneurol-2020-002904
Practical Neurology; Hilton CMH, Specht L et. al.

May 29th, 2021 - Cerebral radiation necrosis is the most serious late reaction to high doses of ionising radiation to the brain, and its treatment is generally unsatisfactory. We present a patient who developed cerebral radiation necrosis after protracted fluorosc...

Radiomics and radiogenomics in gliomas: a contemporary update.
https://doi.org/10.1038/s41416-021-01387-w 10.1093/neuonc/noy131 10.1007/s00401-016-1545-1 10.1148/rg.2017170037 10.3889/oamjms.2015.034 10.1148/radiol.13120118 10.1007/s00330-018-5758-7 10.1007/s11060-017-2587-5 10.1148/radiol.2018171051 10.1016/j.neurad.2014.02.006 10.1007/s11547-016-0720-8 10.1007/s00234-016-1642-9 10.1148/radiol.12122447 10.1007/s00234-015-1500-1 10.1148/radiol.2015151169 10.1016/j.mri.2012.06.010 10.3174/ajnr.A5391 10.1038/ncomms5006 10.1016/j.mric.2016.06.006 10.1016/j.lungcan.2017.10.015 10.1088/1361-6560/ab2f44 10.18383/j.tom.2018.00052 10.1002/jmri.27244 10.3174/ajnr.A4931 10.1371/journal.pone.0125143 10.1117/1.JMI.6.2.024005 10.1109/TMI.2016.2538465 10.1038/srep13087 10.1186/s12859-016-1423-9 10.1109/TPAMI.2005.159 10.1016/j.radonc.2018.03.033 10.3174/ajnr.A5858 10.1016/0031-3203(91)90143-S 10.1109/TSMC.1973.4309314 10.1109/TPAMI.2002.1017623 10.1016/j.eswa.2012.03.029 10.1038/srep37241 10.1038/s41598-018-37615-2 10.1177/0271678X16655549 10.1038/nm.3289 10.1371/journal.pone.0220939 10.1148/radiol.2016161422 10.1038/s41598-017-09048-w 10.1002/jmri.24996 10.1148/radiol.2017160150 10.1093/neuonc/nos335 10.1073/pnas.0801279105 10.1016/j.ejrad.2016.01.013 10.1002/jmri.26010 10.1002/jmri.25835 10.1007/s00330-018-5368-4 10.3174/ajnr.A6075 10.1016/j.ejrad.2019.01.025 10.1016/j.clineuro.2017.12.007 10.1007/s11060-018-2908-3 10.1126/scitranslmed.3002693 10.1038/nm.2682 10.1186/s12967-016-1035-1 10.1126/science.1236062 10.1093/neuonc/nos112 10.1007/s00062-017-0584-x 10.1002/jmri.24913 10.1016/j.diii.2014.06.013 10.1002/jmri.26171 10.1002/nbm.1059 10.1148/radiol.2521081534 10.1002/jmri.26306 10.1002/jmri.22432 10.1016/j.nicl.2018.08.024 10.1016/j.jnci.2016.07.001 10.3390/cells6040045 10.1038/nrclinonc.2012.64 10.1038/s41598-017-18310-0 10.1148/radiol.2016160845 10.1148/radiol.14131691 10.18383/j.tom.2016.00250 10.1016/j.nicl.2018.10.014 10.1093/neuonc/now256 10.1007/s11060-017-2576-8 10.3174/ajnr.A5620 10.1002/mrm.22147 10.4103/ajns.AJNS_81_17 10.1158/1055-9965.EPI-14-0275 10.1093/neuonc/nox092 10.3389/fneur.2019.00460 10.1111/j.1750-3639.2005.tb00115.x 10.1186/1755-8794-7-30 10.3389/fonc.2019.00374 10.1007/s004010000327 10.3171/jns.2006.104.2.233 10.1148/rg.2017160130 10.1155/2018/1729071 10.1002/acm2.12482 10.1118/1.3622605 10.1118/1.3081408 10.1371/journal.pone.0178843 10.1007/s00234-020-02403-1 10.1038/s41598-017-10649-8 10.3389/fnins.2020.00027 10.1148/radiol.2020191145 10.1007/s10278-014-9716-x 10.1186/s13244-019-0795-6 10.1093/neuonc/now135 10.1038/s41568-018-0016-5 10.1007/s00330-017-5108-1 10.1093/neuonc/nox083.197 10.1259/bjr.20160242 10.1109/JBHI.2018.2825027 10.1177/0284185118756951 10.1118/1.4934373 10.1038/s41598-017-14753-7 10.3389/fnins.2019.00810 10.1016/j.suronc.2018.09.002 10.3174/ajnr.A6365 10.18632/oncotarget.17585 10.1007/s11548-017-1691-5 10.1007/s00432-018-2787-1 10.1007/s11060-019-03096-0 10.1016/j.wneu.2019.01.157 10.1186/s12911-020-01163-5
British Journal of Cancer; Singh G, Manjila S et. al.

May 7th, 2021 - The natural history and treatment landscape of primary brain tumours are complicated by the varied tumour behaviour of primary or secondary gliomas (high-grade transformation of low-grade lesions), as well as the dilemmas with identification of ra...

Clinical Review of Computed Tomography and MR Perfusion Imaging in Neuro-Oncology.
https://doi.org/10.1016/j.rcl.2021.01.002
Radiologic Clinics of North America; Trinh A, Wintermark M et. al.

Apr 30th, 2021 - Neuroimaging plays an essential role in the initial diagnosis and continued surveillance of intracranial neoplasms. The advent of perfusion techniques with computed tomography and MR imaging have proven useful in neuro-oncology, offering enhanced ...

Early-onset symptomatic radiation necrosis after stereotactic radiosurgery in the setti...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041142
Medical Dosimetry : Official Journal of the American Asso... Weltman E, Kotecha R

Apr 29th, 2021 - In this brief report, we describe the case of a previously healthy 51-year gentleman who was treated with stereotactic radiosurgery to a dose of 12 Gy to a small right-sided vestibular schwannoma. MRI of the brain performed after treatment reveale...

see more →

News  1 results

FDA Alert on MR-Guided Laser Interstitial Thermal Therapy Devices
https://www.medscape.com/viewarticle/895688

Apr 24th, 2018 - There is a risk of tissue overheating owing to inaccurate magnetic resonance (MR) thermometry with MR-guided laser interstitial thermal therapy (MRgLITT) devices, the US Food and Drug Administration (FDA) said today in a safety communication. The ...

see more →